Year: 2025

Greenway Technologies Announces Appointments of Doug Cogan and C. Dunham Biles

Written by Customer Service on December 10, 2025. Posted in Public Companies.

ARLINGTON, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) — Greenway Technologies, Inc. (OTCQB: GWTI) (“Greenway”), an advanced gas-to-liquids (“GTL”) and gas-to-hydrogen (“GTH”) technology development company, announced today that it has appointed Doug Cogan to serve as the Chief Executive Officer of the Company. Additionally, the Company appointed Mr. Doug Cogan and Mr. C. Dunham Biles to serve as members of its Board of Directors. Mr. Cogan, age 59, has significant global leadership experience as well as energy sector and engineering and technology industry experience. He was with PricewaterhouseCoopers LLP for over 20 years from 1991 to 2022, serving as Partner, Digital Assurance and Transparency, from 2003 to 2022. Mr. Cogan currently serves on the board of directors for Texas Mutual Insurance. He holds a bachelor’s degree in computer...

Hub Cyber Security Successfully Settles Legacy Class Action Litigation and Removes Structural Friction to Accelerate Execution

Written by Customer Service on December 10, 2025. Posted in Public Companies.

TEL AVIV, Israel, Dec. 10, 2025 (GLOBE NEWSWIRE) — HUB Cyber Security Ltd. (Nasdaq: HUBC) (“HUB” or the “Company”), a global leader in confidential computing and secured data fabric technologies, today announced a successful settlement which is intended to resolve the legacy U.S. securities class action related to its 2023 IPO. The settlement, which is subject to final court approval, is designed to close a legacy litigation chapter for a total consideration of $11 million, removing a structural barrier and enabling the Company to operate and focus on its growing business with uncompromised priority. The settlement agreement contemplates a payment of $11 million, financed primarily by HUB’s insurance carriers, ensuring the Company’s cash outlay is thoughtfully addressed, supporting operational priorities and continued execution. HUB...

MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach

Written by Customer Service on December 10, 2025. Posted in Public Companies.

CHICAGO, Dec. 10, 2025 (GLOBE NEWSWIRE) — MAIA Biotechnology (NYSE American: MAIA) – The treatment paradigm for advanced non-small cell lung cancer (NSCLC) is undergoing another shift. After a decade of targeted therapies and checkpoint inhibitors (CPIs) dominating headlines, MAIA believes that a new therapeutic class—telomere-targeting agents—is emerging for the population with substantial unmet medical need: patients without actionable mutations and who no longer respond to CPIs or chemotherapy. This is a segment that existing therapies leave behind. And it is the segment where we believe that ateganosine, developed by MAIA, may soon become one of the most consequential entrants in years. A Market Dominated by Checkpoint Inhibitors—But Vulnerable at Its Edges CPI therapies remain the backbone of NSCLC treatment in patients who...

Awards Glory for Big Screen Entertainment Group

Written by Customer Service on December 10, 2025. Posted in Public Companies.

BSEG Award Winners, Jimmy Jiang and Sandro MonettiBig Screen’s Affiliate company, HiFex, take home awards for their magazine publication 8 years in a row. Seen here, Jimmy Jiang, BSEG’s largest shareholder and Sandro Monetti, BSEG COO and Chief Editor of the magazine,LOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) — Big Screen Entertainment Group (OTC: BSEG) is celebrating a remarkable run of success as members of its creative team continue to shine on some of the industry’s biggest stages. For eight consecutive years, Hollywood International Filmmaker magazine — published by BSEG affiliate HiFex — has been nominated alongside major outlets such as Variety and The Hollywood Reporter, regularly taking home honors. This year, the publication continued its winning streak at the National Arts & Entertainment...

Brandywine Realty Trust Announces Common Quarterly Dividend, and Confirms Fourth Quarter 2025 Earnings Release and Conference Call

Written by Customer Service on December 10, 2025. Posted in Dividend Reports And Estimates.

PHILADELPHIA, Dec. 10, 2025 (GLOBE NEWSWIRE) — Brandywine Realty Trust (NYSE:BDN) announced today that its Board of Trustees has declared a quarterly cash dividend of $0.08 per common share and OP Unit payable on January 22, 2026 to holders of record on January 7, 2026. The quarterly dividend is equivalent to an annual rate of $0.32 per common share. Conference Call and Audio Webcast We expect to release our fourth quarter earnings after market close on Tuesday, February 3, 2026, and we expect to host our fourth quarter conference call on Wednesday, February 4, 2026 at 9:00 a.m. Eastern Time. To access the conference call by phone, please visit this link here, and you will be provided with dial-in details. A live webcast of the conference call will also be available on the Investor Relations page of our website at www.brandywinerealty.com. About...

THEON signs the largest contract ever for 100,000 NVGs with OCCAR, valued at c.€1 billion

Written by Customer Service on December 10, 2025. Posted in Public Companies.

Mr. Christian Hadjiminas, Founder and CEO of THEON, Mr. Joachim Sucker, OCCAR-EA Director, Ms. Christina Canitz, Head of Hensoldt Optronics, Mr. Michael Holzmann, Managing Director of Hensoldt Theon NightVisionMr. Christian Hadjiminas, Founder and CEO of THEON, Mr. Joachim Sucker, OCCAR-EA Director, Ms. Christina Canitz, Head of Hensoldt Optronics, Mr. Michael Holzmann, Managing Director of Hensoldt Theon NightVisionFrom the signing of the agreement Representatives from OCCAR, German and Belgian MoD, THEON and HensoldtFrom the signing of the agreement Representatives from OCCAR, German and Belgian MoD, THEON and HensoldtMr. Christian Hadjiminas, Founder and CEO of THEON, Mr. Joachim Sucker, OCCAR-EA Director, Ms. Christina Canitz, Head of Hensoldt Optronics, Mr. Michael Holzmann, Managing Director of Hensoldt Theon NightVision....

Colliers partners with Google Cloud to accelerate digital and AI-powered innovation

Written by Customer Service on December 10, 2025. Posted in Public Companies.

One of the first in the industry to enter partnership through multi-million-dollar cloud technology investment TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) — Global diversified professional services and investment management company, Colliers (NASDAQ and TSX: CIGI), today announced its partnership to innovate with Google Cloud. As a pillar of Colliers’ multi-year technology transformation strategy, the migration to Google Cloud will unlock advanced analytics and AI for new product development and integrated systems. This strategic focus on smart technologies will boost efficiency, elevate client service, and strengthen operational consistency to drive future innovation. “Colliers is leading the way with bold, purposeful investments in technology that transform how we deliver value across the built environment. These investments align...

Exosens and Theon International announce the signing of a contract with OCCAR for 100,000 night-vision Mikron binoculars, embedding 200,000 Exosens tubes for a total value of approximately €500 million

Written by Customer Service on December 10, 2025. Posted in Public Companies.

EXOSENS AND THEON INTERNATIONAL ANNOUNCE THE SIGNING OF A CONTRACT WITH OCCAR FOR 100,000 NIGHT-VISION MIKRON BINOCULARS, EMBEDDING 200,000 EXOSENS TUBES FOR A TOTAL VALUE OF APPROXIMATELY €500 MILLION, THE LARGEST FIRM NIGHT-VISION AGREEMENT TO DATE AND MAJOR STEP FOR EUROPEAN DEFENCE CAPABILITIES PRESS RELEASEMÉRIGNAC, FRANCE – 10 DECEMBER 2025Exosens and Theon International announce the signing of a contract between the THEON/HENSOLDT consortium and OCCAR for 100,000 binocular MIKRON devices, the largest contract ever concluded in the history of night-vision technology, to supply the German Armed Forces. This contract embeds 200,000 Exosens 16mm tubes for a total value of more than €500 million and follows previous agreements to equip the German Armed Forces, for deliveries from 2027 to 2029. This agreement strengthens Exosens’ position...

EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR

Written by Customer Service on December 10, 2025. Posted in Public Companies.

Villers-lès-Nancy, December 10, 2026, 6:00 p.m. CET – Equasens (ISIN: FR 0012882389 – Ticker: EQS), a leader in digital solutions for healthcare professionals, announces its financial calendar for the 2026 financial year.Events Dates2025 annual revenue February 5, 2026 (after market close)2025 annual results March 30, 2026 (before market opens)2026 Q1 revenue April 29, 2026 (after market close)Annual General Meeting June 25, 20262026 Half-year revenue July 30, 2026 (after market close)2026 Half-year results September 28, 2026 (before market opens)2026 Q3 revenue October 29, 2026 (after market close)About the Equasens Group Founded over 35 years ago, Equasens Group, a leader in digital healthcare solutions, today employs over 1.400 people across Europe. Equasens Group’s specialised business applications...

GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy

Written by Customer Service on December 10, 2025. Posted in Public Companies.

Highly encouraging early data from the ongoing Phase 1b study evaluating investigational drug GNS561 with a MEK inhibitor (MEKi) in KRAS mutated cholangiocarcinoma (CCA), positioning this novel combination as a potential new therapeutic approach for difficult-to-treat cancers:No dose limiting toxicity reached to date, enabling recruitment of a third patient cohort GNS561 and MEKi combination demonstrated disease stabilization in all evaluable patients with evidence of tumor shrinkage in a subset of patients, warranting further investigation Recommended Phase 2 doses expected for 1H26Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), December 10, 2025 – GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases,...

Year: 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals